The Pulse of the Capital of Afghanistan , News for the Afghan Nation
Skip to content (NEXSTAR) – Median household income in the U.S. has reached new heights, the Census Bureau revealed in a data drop on Tuesday. The median household made $87,460 in 2025, the Cens...
(NEXSTAR) Nearly 15% of Americans have tried a GLP-1 and for good reason. The medications show incredible promise in helping people lose a substantial amount of weight. But even people who have ra...
Skip to content by Alix Martichoux - 08/24/26 2:53 PM ET by Alix Martichoux - 08/24/26 2:53 PM ET (NEXSTAR) – From unexpected babies to “Ozempic teeth,” the ultra-popular class of GLP-1 medic...
(NEXSTAR) From unexpected babies to “Ozempic teeth,” the ultra-popular class of GLP-1 medications is turning out to have a few unanticipated side effects. Emerging research shows the drugs, which ...
(NEXSTAR) From unexpected babies to “Ozempic teeth,” the ultra-popular class of GLP-1 medications is turning out to have a few unanticipated side effects. Emerging research shows the drugs, which ...
Skip to content (NEXSTAR) – Don’t be surprised if you start hearing some more coughing in the next few weeks. COVID-19 is once again on the rise in nearly every corner of the U.S. According to m...
Skip to content (NEXSTAR) – The drug-resistant and deadly fungus Candida auris has proven hard to stamp out in 2026. Despite efforts to contain its spread, the fungus is once again on the move, new...
Skip to content (NEXSTAR) – Ivermectin, the anti-parasitic medication most commonly used as a dewormer in animals, is back in the limelight. This time it has nothing to do with COVID-19. More pati...
Skip to content (NEXSTAR) – Health officials around the country are sounding the alarm: Syphilis cases are spiking. New York has seen the number of syphilis cases increase five-fold since 2013, N...
Skip to content (NEXSTAR) – Hospitals, nursing homes and other medical facilities are struggling to gain ground on a drug-resistant and deadly fungus that has infected at least 7,000 people in 2025...